Vertex to end sales of hepatitis C drug Incivek
August 13, 2014 at 14:42 PM EDT
Aug 13 (Reuters) - Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.
